CytoMed Therapeutics
GDTC
#9847
Rank
$27.63 M
Marketcap
$2.40
Share price
1.91%
Change (1 day)
13.51%
Change (1 year)

Earnings for CytoMed Therapeutics (GDTC)

Earnings in 2023: -$3.1 Million USD

According to CytoMed Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -$3.1 Million USD a decrease over its 2022 earnings that were of -$2.25 Million USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for CytoMed Therapeutics from 2020 to 2023

Annual earnings

Year Earnings Change
2023-$3.1 Million37.88%
2022-$2.25 Million56.65%
2021-$1.44 Million3.42%
2020-$1.39 Million